GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AdaptHealth Corp (NAS:AHCO) » Definitions » EV-to-FCF

AHCO (AdaptHealth) EV-to-FCF : 11.98 (As of Jul. 22, 2025)


View and export this data going back to 2018. Start your Free Trial

What is AdaptHealth EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, AdaptHealth's Enterprise Value is $3,290 Mil. AdaptHealth's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 was $275 Mil. Therefore, AdaptHealth's EV-to-FCF for today is 11.98.

The historical rank and industry rank for AdaptHealth's EV-to-FCF or its related term are showing as below:

AHCO' s EV-to-FCF Range Over the Past 10 Years
Min: -308.1   Med: 22.13   Max: 289.93
Current: 11.98

During the past 8 years, the highest EV-to-FCF of AdaptHealth was 289.93. The lowest was -308.10. And the median was 22.13.

AHCO's EV-to-FCF is ranked better than
78.39% of 384 companies
in the Medical Devices & Instruments industry
Industry Median: 27.955 vs AHCO: 11.98

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-07-22), AdaptHealth's stock price is $9.48. AdaptHealth's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was $0.570. Therefore, AdaptHealth's PE Ratio (TTM) for today is 16.63.


AdaptHealth EV-to-FCF Historical Data

The historical data trend for AdaptHealth's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AdaptHealth EV-to-FCF Chart

AdaptHealth Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial 25.67 75.99 -277.57 22.29 14.03

AdaptHealth Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71.55 21.05 15.69 14.03 12.81

Competitive Comparison of AdaptHealth's EV-to-FCF

For the Medical Devices subindustry, AdaptHealth's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AdaptHealth's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AdaptHealth's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where AdaptHealth's EV-to-FCF falls into.


;
;

AdaptHealth EV-to-FCF Calculation

AdaptHealth's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3290.448/274.582
=11.98

AdaptHealth's current Enterprise Value is $3,290 Mil.
AdaptHealth's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $275 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AdaptHealth  (NAS:AHCO) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

AdaptHealth's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=9.48/0.570
=16.63

AdaptHealth's share price for today is $9.48.
AdaptHealth's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.570.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


AdaptHealth EV-to-FCF Related Terms

Thank you for viewing the detailed overview of AdaptHealth's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


AdaptHealth Business Description

Traded in Other Exchanges
N/A
Address
220 West Germantown Pike, Suite 250, Plymouth Meeting, PA, USA, 19462
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.
Executives
Jason A Clemens officer: Chief Financial Officer 220 WEST GERMANTOWN PIKE, SUITE 250, C/O ADAPTHEALTH LLC, PLYMOUTH MEETING PA 19462
Dale B Wolf director
Shaw Rietkerk officer: Chief Revenue Officer C/O ADAPTHEALTH LLC, 220 WEST GERMANTOWN PIKE, SUITE 250, PLYMOUTH MEETING PA 19462
Williams David Solomon Iii director 6272 CONDON AVE, LOS ANGELES CA 90056
James E Flynn director, 10 percent owner, other: Director by Deputization 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Albert A. Prast officer: Chief Technology Officer 3325 BARTLETT BLVD., ORLANDO FL 32811
Skyknight Aero Holdings, Llc director C/O SKYKNIGHT CAPITAL, L.P., ONE LETTERMAN DR., BLDG. C, SUITE 3-950, SAN FRANCISCO CA 94129
Christine E. Archbold officer: Chief Accounting Officer FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SEL 8EZ
Everest Hill Group Inc. 10 percent owner TROPIC ISLE BUILDING, P O BOX 3331, ROAD TOWN TORTOLA D8 VG 1110
Daniel Bunting officer: COO - Branch Operations 12200 N.W. AMBASSADOR DRIVE, SUITE 326, KANSAS CITY MO 64163
Christopher J Joyce officer: General Counsel C/O ALLIANCE ENTERTAINMENT CORP, 110 EAST 59TH STREET 18TH FLOOR, NEW YORK NY 10022
Skyknight Aero Holdings Ii, Llc director C/O SKYKNIGHT CAPITAL, L.P., ONE LETTERMAN DR., BLDG. C, SUITE 3-950, SAN FRANCISCO CA 94129
Skyknight Capital, L.p. director C/O SKYKNIGHT CAPITAL, ONE LETTERMAN DR., BLDG. C, SUITE 3-950, SAN FRANCISCO CA 94129
Skyknight Capital Fund Ii, L.p. director ONE LETTERMAN DRIVE, BUILDING C, SUITE 3-950, SAN FRANCISCO CA 94129
Stephen P Griggs director, officer: Co-Chief Executive Officer 1360 PLACE VENDOME, WINTER PARK FL 32789